Ezetimibe CAS 163222-33-1 Puritas 98.5%~ 102.0% (HPLC)
Manufacturer Supple;Qualitas et auctor pretium
Supple Commercial Ezetimibe (CAS: 163222-33-1) Intermedia:
(S)-(+)-4-Phenyl-2-oxazolidinone CAS: 99395-88-7
CAS: 112022-83-0
4-(4-Fluorobenzoyl) acidum butyricum CAS: 149437-76-3
4-[[(4-Fluorophenyl)imino]methyl]-phenol CAS: 3382-63-6
N-(4-(Benzyloxy) benzyliden) -4-fluoroaniline CAS: 70627-52-0
(3R,4S)-4-[4-(Benzyloxy)phenyl]-1-(4-fluorophenyl)-3-[3-(4-fluorophenyl)-3-oxopropyl]azetidin-2-one CAS 190595-65- 4
(4S)-3-[5-(4-Fluorophenyl)-1,5-dioxopenyl]-4-phenyl-2-oxazolidinone CAS: 189028-93-1
(4S) -3-[(5S)-5-(4-Fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolidin-2-one CAS: 189028-95-3
Ezetimibe CAS: 163222-33-1
Nomen chemicum | (3R,4S) -1-(4-Fluorophenyl) -3-[(S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-one |
Synonyma | Ezetimibe |
CAS Number | 163222-33-1 |
CATTUS Number | RF-API02 |
Stock Status | In Stock, Productio Ascendite usque ad Centum chiliogrammata |
Formulae hypotheticae | C24H21F2NO3 |
M. Pondus | 409.43 |
Liquescens punctum | 162.0 ~ 166.0℃ |
Brand | Ruifu Chemical |
Item | Specifications |
Aspectus | Alba ad Off-White pulveris |
Lepidium sativum | Per IR, HPLC |
Puritas / Analysis Methodus | 98.5%~ 102.0% (HPLC) |
Imprimis Rotationes | -25.0°~ -0.0° |
Humor (KF) | ≤0.50% |
Cinis sululated | ≤0.10% |
Metalla gravis | ≤0.002% |
Enantiomer | ≤0.30% |
Unius Max.immunditia | ≤0.50% |
Totalis immunditias | ≤1.0% |
Test Standard | Enterprise Standard |
Consuetudinem | Ezetimibe (CAS: 163222-33-1) API |
sarcina: Utrem, aluminium foil, pera, cardboard tympanum, 25kg/Drum, vel secundum exigentiam emptoris.
Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine, humore et pestis infestatione.
Ezetimibe (CAS: 163222-33-1) est vecturae cholesteroli inhibitoris ligantis ad NPC1L1, ad genus substantiarum pertinet ad gradus cholesteroli inferioris in sanguine medicamentum quod gradus cholesteroli demittit.decrescente cholesteroli effusio in tenui intestino.Sola adhiberi potest cum alia medicamenta cholesterol-minanda non tolerantur, aut simul cum statinis (ex. gr. ezetimibe/simvastatin) cum statins solus cholesterolum non refrenat.Ezetimibe solum ore sumitur, vel ut iunctura tabula cum vel simvastatin vel atorvastatin.Ezetimibe anno 2002 ab FDA probata est, sub nomine commercii Zetia.Laudatur in usu in UE ut Ezetrol et alia nomina artis commercii.Fiunt per multi-gradum chemicum processum.